赛诺医疗
(688108)
| 流通市值：119.66亿 | | | 总市值：119.66亿 |
| 流通股本：4.16亿 | | | 总股本：4.16亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 240,476,013.66 | 100,849,103.23 | 458,739,271.36 | 318,486,443.24 |
| 营业收入 | 240,476,013.66 | 100,849,103.23 | 458,739,271.36 | 318,486,443.24 |
| 二、营业总成本 | 234,401,263.96 | 106,844,000.33 | 490,838,082.21 | 355,578,619.17 |
| 营业成本 | 87,427,710.14 | 40,680,235.11 | 174,587,205.02 | 123,276,333.08 |
| 税金及附加 | 2,866,304.24 | 1,202,230.15 | 3,645,204.88 | 2,059,947.27 |
| 销售费用 | 35,499,042.15 | 15,103,424.6 | 78,953,775.78 | 55,039,586.14 |
| 管理费用 | 46,927,417.69 | 22,321,712.5 | 89,493,215.42 | 65,686,835.82 |
| 研发费用 | 59,707,969.51 | 26,583,284.27 | 140,557,411.47 | 106,407,498.18 |
| 财务费用 | 1,972,820.23 | 953,113.7 | 3,601,269.64 | 3,108,418.68 |
| 其中:利息费用 | 2,519,833.22 | 1,325,300.18 | 5,612,265.45 | 4,197,871.37 |
| 其中:利息收入 | 1,261,644.05 | 714,748.88 | 2,421,000.73 | 1,681,037.77 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | - | - | 11,194,579.02 | 11,194,579.02 |
| 资产处置收益 | - | - | 287,342.75 | - |
| 资产减值损失(新) | 3,358,349.76 | 3,735,993.18 | -18,054,165.47 | -7,904,949.4 |
| 信用减值损失(新) | -39,528.58 | -47,658.14 | 426,622.77 | 113,867.28 |
| 其他收益 | 11,872,051.17 | 6,567,123.44 | 21,278,567.97 | 16,564,853.19 |
| 四、营业利润 | 21,265,622.05 | 4,260,561.38 | -16,965,863.81 | -17,123,825.84 |
| 加:营业外收入 | 2,256,291.15 | 69.69 | 617,920.02 | 653,763.92 |
| 减:营业外支出 | 511,350.83 | 13,704.36 | 810,410.9 | 254,128.28 |
| 五、利润总额 | 23,010,562.37 | 4,246,926.71 | -17,158,354.69 | -16,724,190.2 |
| 减:所得税费用 | 9,842,151.32 | 1,531,549.45 | -13,268,874.08 | -1,792,789.37 |
| 六、净利润 | 13,168,411.05 | 2,715,377.26 | -3,889,480.61 | -14,931,400.83 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 13,168,411.05 | 2,715,377.26 | -3,889,480.61 | -14,931,400.83 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 13,841,586.81 | 2,969,330.7 | 1,497,793.42 | -10,915,893.04 |
| 少数股东损益 | -673,175.76 | -253,953.44 | -5,387,274.03 | -4,015,507.79 |
| 扣除非经常损益后的净利润 | 7,977,673.71 | 552,547.61 | -17,518,901.65 | -28,596,955.89 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.03 | 0.01 | 0 | -0.03 |
| (二)稀释每股收益 | 0.03 | 0.01 | 0 | -0.03 |
| 八、其他综合收益 | 761,914.42 | 127,504.82 | -1,086,798.73 | -1,557,247.24 |
| 归属于母公司股东的其他综合收益 | 761,914.42 | 127,504.82 | -1,086,798.73 | -1,557,247.24 |
| 九、综合收益总额 | 13,930,325.47 | 2,842,882.08 | -4,976,279.34 | -16,488,648.07 |
| 归属于母公司股东的综合收益总额 | 14,603,501.23 | 3,096,835.52 | 410,994.69 | -12,473,140.28 |
| 归属于少数股东的综合收益总额 | -673,175.76 | -253,953.44 | -5,387,274.03 | -4,015,507.79 |
| 公告日期 | 2025-08-22 | 2025-04-26 | 2025-04-26 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |